Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies

Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies

Background: To date, no specific scales have been developed to explore the impact of neuromyelitis optica spectrum disorder (NMOSD)-related disability on quality of life (QoL). The Expanded Disability Status Scale (EDSS) and the EuroQol 5-dimensions (EQ-5D) have been used to assess disability and Qo...

Full description

Bibliographic Details
Main Authors: Becker, U. (Author), Costantino, C. (Author), Damonte, E. (Author), Haycox, A.R (Author), Klingelschmitt, G. (Author), Levy, M. (Author), Maio, D.D (Author), Szczechowski, L. (Author), von Büdingen, H.C (Author), Wallenstein, G. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
Association
clinical trial
controlled study
disabled person
Disabled Persons
EDSS
EQ-5D
human
Humans
immunosuppressive agent
Immunosuppressive Agents
multicenter study
myelooptic neuropathy
Neuromyelitis Optica
Neuromyelitis optica spectrum disorder
NMO
quality of life
Quality of Life
questionnaire
randomized controlled trial
Surveys and Questionnaires
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items